Home › Funds › Washington Trust Advisors, Inc. › MDLN
Washington Trust Advisors, Inc. position in MDLN
MEDLINE INC · Health Care
Washington Trust Advisors, Inc. reported holding 167,085 shares of MDLN (MEDLINE INC) in its Q3 2026 13F filing — a position valued at US$5.8M, representing 0.42% of its reported portfolio and ranking #49 among its reported holdings. Washington Trust Advisors, Inc. has disclosed MDLN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Washington Trust Advisors, Inc.'s MDLN position evolved
Washington Trust Advisors, Inc. first disclosed a stake in MDLN in Q2 2026 at 136,179 shares (US$5.4M). The position peaked in Q3 2026 at 167,085 shares, worth US$5.8M. Across 2 filings, Washington Trust Advisors, Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 167,085 shares valued at US$5.8M — an increase of 30,906 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 136.18K | $5.37M | New |
| Q3 2026 | 167.09K | $5.80M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MDLN and 13F data
MDLN (MEDLINE INC) is a Health Care company. 94 other funds we track also report a position in MDLN — the largest reported positions include Carlyle Group Inc. (US$6.49B), Blackstone Inc. (US$4.01B), H&F Corporate Investors X, Ltd. (US$2.46B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MDLN
- Carlyle Group Inc. 187.08M sh · $6.49B · Q3 2026
- Blackstone Inc. 101.79M sh · $4.01B · Q2 2026
- H&F Corporate Investors X, Ltd. 70.87M sh · $2.46B · Q3 2026
- Lone Pine Capital 20.97M sh · $826.99M · Q2 2026
- LONE PINE CAPITAL LLC 20.97M sh · $826.99M · Q2 2026
- Egerton Capital (UK) LLP 13.28M sh · $460.92M · Q3 2026
- SurgoCap Partners LP 7.49M sh · $295.31M · Q2 2026
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 7.36M sh · $290.10M · Q2 2026
- Alyeska Investment Group, L.P. 6.81M sh · $268.55M · Q2 2026
- BANQUE PICTET & CIE SA 7.46M sh · $258.69M · Q3 2026
- Unisphere Establishment 3.68M sh · $145.24M · Q2 2026
- SEVEN GRAND MANAGERS, LLC 3.65M sh · $144.00M · Q2 2026
More on Washington Trust Advisors, Inc.
FAQ
How long has Washington Trust Advisors, Inc. held MDLN?
Washington Trust Advisors, Inc. has disclosed MDLN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Washington Trust Advisors, Inc.'s current position in MDLN?
As of Q3 2026, Washington Trust Advisors, Inc. holds 167.09K shares of MDLN (MEDLINE INC), valued at $5.80M, representing 0.42% of its reported portfolio and ranking #49.
Has Washington Trust Advisors, Inc. been buying or selling MDLN?
In the latest 13F filing (Q3 2026), Washington Trust Advisors, Inc. increased its position in MDLN. The position peaked in Q3 2026 at 167.09K shares.
Which other funds hold MDLN?
Other major institutional holders of MDLN include Carlyle Group Inc., Blackstone Inc., H&F Corporate Investors X, Ltd., among 94 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.